These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9765028)
1. Effect of plasmid DNA on immunogenicity of HBsAg-anti-HBs complex. Qu D; Yuan ZH; He LF; Yang L; Li GD; Wen YM Viral Immunol; 1998; 11(2):65-72. PubMed ID: 9765028 [TBL] [Abstract][Full Text] [Related]
2. DNA-mediated immunization of mice with plasmid encoding HBs antigen. Yoon SJ; Park JW; Ahn SY; Choe BK; Suh MH J Korean Med Sci; 1999 Apr; 14(2):187-92. PubMed ID: 10331566 [TBL] [Abstract][Full Text] [Related]
3. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. Chow YH; Huang WL; Chi WK; Chu YD; Tao MH J Virol; 1997 Jan; 71(1):169-78. PubMed ID: 8985336 [TBL] [Abstract][Full Text] [Related]
4. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine. Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297 [TBL] [Abstract][Full Text] [Related]
5. Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen. Fomsgaard A; Nielsen HV; Bryder K; Nielsen C; Machuca R; Bruun L; Hansen J; Buus S Scand J Immunol; 1998 Apr; 47(4):289-95. PubMed ID: 9600309 [TBL] [Abstract][Full Text] [Related]
6. Comparing the immunogenicity of hepatitis B virus S gene variants by DNA immunization. Wu L; Yuan ZH; Liu F; Waters JA; Wen YM Viral Immunol; 2001; 14(4):359-67. PubMed ID: 11792065 [TBL] [Abstract][Full Text] [Related]
7. Plasmids enriched with CpG motifs activate human peripheral blood mononuclear cells in vitro and enhance th-1 immune responses to hepatitis B surface antigen in mice. Chen Z; Cao J; Liao X; Ke J; Zhu S; Zhao P; Qi Z Viral Immunol; 2011 Jun; 24(3):199-209. PubMed ID: 21668361 [TBL] [Abstract][Full Text] [Related]
8. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant. Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475 [TBL] [Abstract][Full Text] [Related]
9. Long-term persistence of hepatitis B surface antigen and antibody induced by DNA-mediated immunization results in liver and kidney lesions in mice. Zi XY; Yao YC; Zhu HY; Xiong J; Wu XJ; Zhang N; Ba Y; Li WL; Wang XM; Li JX; Yu HY; Ye XT; Lau JT; Hu YP Eur J Immunol; 2006 Apr; 36(4):875-86. PubMed ID: 16552712 [TBL] [Abstract][Full Text] [Related]
10. Antigen-antibody complex as therapeutic vaccine for viral hepatitis B. Wen YM; Qu D; Zhou SH Int Rev Immunol; 1999; 18(3):251-8. PubMed ID: 10614727 [TBL] [Abstract][Full Text] [Related]
11. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection. Du DW; Jia ZS; Li GY; Zhou YY World J Gastroenterol; 2003 Jan; 9(1):108-11. PubMed ID: 12508362 [TBL] [Abstract][Full Text] [Related]
12. [Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg]. Du X; Wang J; Kang Y; Xiao W; Zhao G; Wang B Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):938-42. PubMed ID: 19873759 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo. Zhu W; Wu C; Deng W; Pei R; Wang Y; Cao L; Qin B; Lu M; Chen X PLoS One; 2012; 7(9):e45146. PubMed ID: 23024803 [TBL] [Abstract][Full Text] [Related]
14. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice]. Li L; Tian YJ; Shen H; Zhao XP; Yang DL Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026 [TBL] [Abstract][Full Text] [Related]
15. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity. Wu L; He JW; Yao X; Li HM; Wen YM J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722 [TBL] [Abstract][Full Text] [Related]
16. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand]. Ke JS; Zhao P; Cao J; Yu JP; Qi ZT Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314 [TBL] [Abstract][Full Text] [Related]
17. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization. Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876 [TBL] [Abstract][Full Text] [Related]
18. Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies. Weeratna RD; Brazolot Millan CL; McCluskie MJ; Siegrist CA; Davis HL FEMS Immunol Med Microbiol; 2001 Apr; 30(3):241-7. PubMed ID: 11335145 [TBL] [Abstract][Full Text] [Related]
19. [Reciprocal priming-boosting role of HBsAg and DNA vaccines]. Zhou Z; Chen WS; Zhang HH; Yao JL Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517 [TBL] [Abstract][Full Text] [Related]
20. Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent. Kondo R; Feitelson MA; Strayer DS Gene Ther; 1998 May; 5(5):575-82. PubMed ID: 9797861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]